Log in

Taro Pharmaceutical Industries News Headlines (NYSE:TARO)

$72.95
+0.45 (+0.62 %)
(As of 02/21/2020 02:31 AM ET)
Today's Range
$72.05
Now: $72.95
$73.65
50-Day Range
$72.50
MA: $81.71
$89.13
52-Week Range
$72.04
Now: $72.95
$109.42
Volume38,035 shs
Average Volume44,928 shs
Market Capitalization$2.79 billion
P/E Ratio11.29
Dividend YieldN/A
Beta0.6

Headlines

Taro Pharmaceutical Industries (NYSE TARO) News Headlines

Source:
DateHeadline
BRIEF-Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall Of Phenytoin Oral Suspension USP, 125 Mg/5 MlBRIEF-Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall Of Phenytoin Oral Suspension USP, 125 Mg/5 Ml
www.reuters.com - February 20 at 11:18 PM
Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5 mL Due to Possible Underdosing or OverdosingTaro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5 mL Due to Possible Underdosing or Overdosing
finance.yahoo.com - February 20 at 6:18 PM
Gabapentin Drug Market: Facts, Figures and Analytical Insights 2020-2026Gabapentin Drug Market: Facts, Figures and Analytical Insights 2020-2026
www.marketwatch.com - February 19 at 8:58 AM
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Short Interest Down 5.1% in JanuaryTaro Pharmaceutical Industries Ltd. (NYSE:TARO) Short Interest Down 5.1% in January
www.americanbankingnews.com - February 16 at 3:34 AM
 Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Receives Average Rating of "Strong Buy" from Analysts Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Receives Average Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - February 11 at 9:50 AM
Sun Pharmaceuticals Industries Ltd. (SMPQY) Q3 2020 Results - Earnings Call TranscriptSun Pharmaceuticals Industries Ltd. (SMPQY) Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - February 7 at 5:08 PM
Earnings Beat: Taro Pharmaceutical Industries Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsEarnings Beat: Taro Pharmaceutical Industries Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
finance.yahoo.com - February 5 at 5:29 PM
Former Taro Pharmaceutical VP Of Sales And Marketing Indicted for Price FixingFormer Taro Pharmaceutical VP Of Sales And Marketing Indicted for Price Fixing
finance.yahoo.com - February 5 at 12:29 PM
Taro PharmaceuticalTaro Pharmaceutical
www.benzinga.com - February 5 at 7:28 AM
Taro down 4% after FQ3 report, continued sales headwindsTaro down 4% after FQ3 report, continued sales headwinds
seekingalpha.com - February 4 at 12:25 PM
Taro Pharmaceutical Industries (NYSE:TARO) Releases Quarterly  Earnings Results, Beats Estimates By $0.22 EPSTaro Pharmaceutical Industries (NYSE:TARO) Releases Quarterly Earnings Results, Beats Estimates By $0.22 EPS
www.americanbankingnews.com - February 4 at 10:01 AM
Taro Pharmaceutical Industries (NYSE:TARO) Receives Buy Rating from HC WainwrightTaro Pharmaceutical Industries (NYSE:TARO) Receives Buy Rating from HC Wainwright
www.americanbankingnews.com - February 4 at 7:38 AM
Taro Pharmaceutical EPS beats by $0.22, misses on revenueTaro Pharmaceutical EPS beats by $0.22, misses on revenue
seekingalpha.com - February 4 at 7:24 AM
Taro Provides Results for December 31, 2019Taro Provides Results for December 31, 2019
finance.yahoo.com - February 3 at 7:52 PM
Taro Pharmaceutical (TARO) Surpasses Q3 Earnings EstimatesTaro Pharmaceutical (TARO) Surpasses Q3 Earnings Estimates
finance.yahoo.com - February 3 at 7:52 PM
Taro Pharmaceutical Industries (TARO) to Release Quarterly Earnings on MondayTaro Pharmaceutical Industries (TARO) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - January 29 at 10:36 AM
Lamictal Market 2020 Industry Share, Outlook, Growth Factors, Demand Analysis, Key Manufacturers and Future Scenario by 2026Lamictal Market 2020 Industry Share, Outlook, Growth Factors, Demand Analysis, Key Manufacturers and Future Scenario by 2026
www.marketwatch.com - January 29 at 9:03 AM
Taro to Announce Third Quarter Results on February 3, 2020Taro to Announce Third Quarter Results on February 3, 2020
finance.yahoo.com - January 28 at 6:32 PM
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Short Interest Down 20.7% in JanuaryTaro Pharmaceutical Industries Ltd. (NYSE:TARO) Short Interest Down 20.7% in January
www.americanbankingnews.com - January 27 at 10:58 AM
Topical Antibiotic Pharmaceuticals Market Trends, Analysis, Statistics and Forecast 2019 to 2026Topical Antibiotic Pharmaceuticals Market Trends, Analysis, Statistics and Forecast 2019 to 2026
www.marketwatch.com - January 18 at 5:54 PM
Mouth Ulcers Drugs Market Analysis (2020 - 2025)| Expert Guide to Boost the Industry in Global Market ShareMouth Ulcers Drugs Market Analysis (2020 - 2025)| Expert Guide to Boost the Industry in Global Market Share
www.marketwatch.com - January 18 at 5:54 PM
Volatility 101: Should Taro Pharmaceutical Industries (NYSE:TARO) Shares Have Dropped 44%?Volatility 101: Should Taro Pharmaceutical Industries (NYSE:TARO) Shares Have Dropped 44%?
finance.yahoo.com - January 16 at 5:35 PM
Relative Strength Alert For Taro Pharmaceutical IndustriesRelative Strength Alert For Taro Pharmaceutical Industries
www.nasdaq.com - January 16 at 12:18 AM
Taro Pharma Recalls Certain Lot Of Lamotrigine TabletsTaro Pharma Recalls Certain Lot Of Lamotrigine Tablets
www.nasdaq.com - January 13 at 5:17 PM
Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count BottlesTaro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles
finance.yahoo.com - January 10 at 6:46 PM
Taro Announces Final Results of Its Tender OfferTaro Announces Final Results of Its Tender Offer
finance.yahoo.com - December 19 at 11:28 PM
Taro Pharmaceutical Industries Ltd. (TARO): Hedge Funds In Wait-and-See ModeTaro Pharmaceutical Industries Ltd. (TARO): Hedge Funds In Wait-and-See Mode
finance.yahoo.com - December 19 at 6:28 PM
Lidocaine Ointment Market | Recent Trends Analysis Focus on Technological Innovations, Key Developments, And Future StrategiesLidocaine Ointment Market | Recent Trends Analysis Focus on Technological Innovations, Key Developments, And Future Strategies
www.marketwatch.com - December 18 at 8:25 AM
CORRECTING and REPLACING Taro Announces Preliminary Results of Its Tender OfferCORRECTING and REPLACING Taro Announces Preliminary Results of Its Tender Offer
finance.yahoo.com - December 17 at 11:42 PM
Mouth Ulcers Drugs Market Next Big Thing (2020-2029) | Profiling Key Players : BLISTEX, Bristol-Myers Squibb Company and 3MMouth Ulcers Drugs Market Next Big Thing (2020-2029) | Profiling Key Players : BLISTEX, Bristol-Myers Squibb Company and 3M
www.marketwatch.com - December 17 at 8:41 AM
BRIEF-Taro Announces Resignation Of Chief Financial OfficerBRIEF-Taro Announces Resignation Of Chief Financial Officer
www.msn.com - December 6 at 11:59 PM
Taro Announces Resignation of Chief Financial OfficerTaro Announces Resignation of Chief Financial Officer
finance.yahoo.com - December 6 at 8:57 AM
Calculating The Fair Value Of Taro Pharmaceutical Industries Ltd. (NYSE:TARO)Calculating The Fair Value Of Taro Pharmaceutical Industries Ltd. (NYSE:TARO)
finance.yahoo.com - November 29 at 12:00 PM
Taros tavaborole gets tentative FDA OKTaro's tavaborole gets tentative FDA OK
seekingalpha.com - November 21 at 5:56 PM
Taro Pharma up 12% on share buybacksTaro Pharma up 12% on share buybacks
seekingalpha.com - November 17 at 6:03 PM
BRIEF-Taro Announces Commencement Of Tender Offer To Repurchase Up To $225 Million In Value Of Its Ordinary SharesBRIEF-Taro Announces Commencement Of Tender Offer To Repurchase Up To $225 Million In Value Of Its Ordinary Shares
www.msn.com - November 15 at 11:18 PM
Taro Pharma up 12% on share buy backsTaro Pharma up 12% on share buy backs
seekingalpha.com - November 15 at 1:17 PM
Taro Announces Commencement of Tender Offer to Repurchase up to $225 Million in Value of Its Ordinary SharesTaro Announces Commencement of Tender Offer to Repurchase up to $225 Million in Value of Its Ordinary Shares
finance.yahoo.com - November 15 at 1:17 PM
Myelofibrosis Treatment Market Global Research and Clinical Analysis 2019-2025Myelofibrosis Treatment Market Global Research and Clinical Analysis 2019-2025
www.marketwatch.com - November 13 at 1:30 PM
Sun Pharmaceuticals Industries Ltd. (SMPQY) Q2 2020 Results - Earnings Call TranscriptSun Pharmaceuticals Industries Ltd. (SMPQY) Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 1:36 PM
Edited Transcript of TARO earnings conference call or presentation 5-Nov-19 1:00pm GMTEdited Transcript of TARO earnings conference call or presentation 5-Nov-19 1:00pm GMT
finance.yahoo.com - November 10 at 7:42 PM
Maintain ‘buy’ on Sun Pharma, target price Rs 515Maintain ‘buy’ on Sun Pharma, target price Rs 515
www.msn.com - November 8 at 9:26 PM
Taro Pharmaceutical Industries (TARO) Q2 2019 Earnings Call TranscriptTaro Pharmaceutical Industries (TARO) Q2 2019 Earnings Call Transcript
www.nasdaq.com - November 5 at 11:27 PM
Taro Pharmaceutical Industries Ltd. (TARO) CEO Uday Baldota on Q2 2020 Results - Earnings Call TranscriptTaro Pharmaceutical Industries Ltd. (TARO) CEO Uday Baldota on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 6:26 PM
Taro Provides Results for September 30, 2019Taro Provides Results for September 30, 2019
finance.yahoo.com - November 4 at 6:39 PM
Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO) Earnings Report DateTaro Pharmaceutical Industries Ltd. Ordinary Shares (TARO) Earnings Report Date
www.nasdaq.com - November 3 at 11:27 PM
Taro to Announce Second Quarter Results on November 4, 2019Taro to Announce Second Quarter Results on November 4, 2019
finance.yahoo.com - October 25 at 6:49 PM
Taro Pharmaceutical Industries (TARO) Doesn’t Excite Hedge FundsTaro Pharmaceutical Industries (TARO) Doesn’t Excite Hedge Funds
finance.yahoo.com - October 24 at 5:41 PM
Foamix settles patent dispute with Teva; shares up 6% premarketFoamix settles patent dispute with Teva; shares up 6% premarket
seekingalpha.com - October 21 at 8:55 AM
Global Oral Ulcer Drug Market 2019: Blistex, Church and Dwight, Blairex LaboratoriesGlobal Oral Ulcer Drug Market 2019: Blistex, Church and Dwight, Blairex Laboratories
www.marketwatch.com - October 9 at 4:33 AM
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel